Home / AJANTPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AJANTPHARM.NS make money? Does AJANTPHARM.NS have pricing power? What's the Earnings Whisper? Will AJANTPHARM.NS profit more as the business scales? What is AJANTPHARM.NS's management track record? Is AJANTPHARM.NS's current price justified?

Ajanta Pharma Limited

₹3329 +$390.60 (+13.29%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹3359.4

Day Range

₹3309₹3381

Year Range

₹2382₹3796

Market Cap

415.99B

AVG Volume

107.33K

Trailing/Forward PE

36.65/28.74

PEG ratio

2.59

Dividend Yield

1.80%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

AJANTPHARM.NS Revenue (INR) by year
Period	Revenue (INR)
2026	54.53B
2025	45.88B
2024	41.62B
2023	37.08B
2022	32.84B
2021	28.47B
2020	25.62B
2019	20.16B
2018	21.31B
2017	20.02B

Net Income (INR) · A

AJANTPHARM.NS Net Income (INR) by year
Period	Net Income (INR)
2026	10.56B
2025	9.2B
2024	8.16B
2023	5.88B
2022	7.13B
2021	6.54B
2020	4.68B
2019	3.87B
2018	4.69B
2017	5.07B

Operating Income (INR) · A

AJANTPHARM.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	24.54B
2025	20.6B
2024	13.21B
2023	7.21B
2022	8.12B
2021	8.92B
2020	6.1B
2019	4.95B
2018	5.89B
2017	6.13B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Ajanta Pharma Limited

Video analysis: AJANTPHARM.NS

News: AJANTPHARM.NS

Similar companies